Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists

FierceBiotechDespite data concerns, Roche’s oral SERD can still be largest product in company history: exec

FierceBiotechRegeneron ushers in new genetic medicine era with groundbreaking gene therapy approval

Thermo FisherThermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals

AgilentEarnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN

10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView

FierceBiotechKurma closes €215M Europe-focused fund to spread across 20 biotechs

FierceBiotechPfizer cans work on next-gen conjugate in cancer patients

BioWorldAnglonordic panelists discuss how to get the most from AI

Thermo FisherThermo Fisher falls after earnings top estimates, but growth concerns persist - Yahoo Finance

Thermo FisherThermo Fisher (TMO) Q1 2026 Earnings Transcript - The Motley Fool

Lonza NewsBanks kick off talks on Lone Star’s $1.75 billion Lonza unit debt - Bloomberg News - TradingView

PLoS BiologySea urchin eggs contain a plastid-derived structure that contributes to their development